{"id":"W2564757287","doi":"10.2217/fon-2016-0444","title":"Phase II Trial of Capecitabine Plus Erlotinib Versus Capecitabine Alone in Patients with Advanced Colorectal Cancer","year":2017,"lang":"en","type":"article","venue":"Future Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"Lions Gate Hospital; Centre Hospitalier de l’Université de Montréal; Cancer Care Ontario; Western University","funders":"","keywords":"Capecitabine; KRAS; Medicine; Erlotinib; Colorectal cancer; Internal medicine; Oncology; Tyrosine-kinase inhibitor; Gastroenterology; Cancer; Epidermal growth factor receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001475821,0.00203526,0.00239425,0.0004416055,0.0003731101,0.001114841,0.0008302171,0.001630327,0.006851769],"category_scores_gemma":[0.001344038,0.0006491696,0.001538947,0.0004948046,0.0008581991,0.001062099,0.0003494754,0.003491397,0.001104542],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009096998,"about_ca_system_score_gemma":0.001206805,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009564388,"about_ca_topic_score_gemma":0.003061492,"domain_scores_codex":[0.9995472,0.0002359523,0.00002189749,0.00007939347,0.0000311502,0.00008444752],"domain_scores_gemma":[0.9993061,0.0001561438,0.0001429617,0.00005043924,0.00003725085,0.0003071086],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9490215,0.01663962,0.0008527864,0.0005248219,0.0006936524,0.00008004092,0.00006948527,0.0008394707,0.004444219,0.00010833,0.001631163,0.025095],"study_design_scores_gemma":[0.8736259,0.1227789,0.001707599,0.000021758,0.0001863399,0.00005030421,0.00001416393,0.0004269042,0.0004536829,0.00008341467,0.0006407679,0.00001039779],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9842533,0.00458673,0.0006056072,0.001377861,0.0006686344,0.003510059,0.001210326,0.0001218594,0.003665577],"genre_scores_gemma":[0.9821016,0.002936414,0.001547986,0.001405448,0.0005676843,0.003324219,0.002001671,0.00002734406,0.006087672],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006851769,"threshold_uncertainty_score":0.02292144,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01852905303029057,"score_gpt":0.3391485561134127,"score_spread":0.3206195030831221,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}